Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 1.3B$US for a 2030 drug

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Aug 15, 2023 1:33pm

317 Views

Post# 35589369

RE:RE:RE:1.3B$US for a 2030 drug

RDW doesn't seem old to me. CEOs all seem to be older folks.

I think this is a legacy deal for RDW. He wants to be part of something bigger in changing cancer care and helping develop a new sub-field of oncology. Making money would be fine too, but I don't see him rushing to seel and exit at all. IMO

Dr. Mandel I can't speak to as he hasn't done any youtube interviews. :)

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December